Document Detail


Synthesis, anti-HIV and antitubercular activities of isatin derivatives.
MedLine Citation:
PMID:  16649536     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
HIV is the most significant risk factor for many opportunistic infections like tuberculosis. In this study, we designed an isatinimino lead compound as a novel non-nucleoside reverse transcriptase inhibitor with antimycobacterial properties for the effective treatment of AIDS and AIDS-related tuberculosis. Among the compounds sythesized, 1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-7[[N4-[3'-[(4,6-dimethylpyrimidin-2-yl)benzenesulfonamido-4-yl]imino-1'-(5-fluoroisatinyl)]methyl]-3-methyl N1-piperazinyl]-3-quinoline carboxylic acid (9) emerged as the most potent broad-spectrum chemotherapeutic agent active against HIV (EC50: 12.1 microg/ml), and Mycobacterium tuberculosis (MIC: 1.22 microg/ml).
Authors:
D Sriram; P Yogeeswari; K Meena
Related Documents :
22163386 - A bankruptcy problem approach to load-shedding in multiagent-based microgrid operation.
12125816 - Bacterial bioinformatics: pathogenesis and the genome.
17300556 - Development of ethnic disparities in internalizing and externalizing problems from adol...
890116 - The goldenhar syndrome: a natural history.
17054746 - Community response to intermittent preventive treatment delivered to infants (ipti) thr...
12636216 - Cytokine manipulation of the wound.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Die Pharmazie     Volume:  61     ISSN:  0031-7144     ISO Abbreviation:  Pharmazie     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-05-02     Completed Date:  2006-05-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9800766     Medline TA:  Pharmazie     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  274-7     Citation Subset:  IM    
Affiliation:
Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Pilani 333031, India. dsriram@bits-pilani.ac.in
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-HIV Agents / chemical synthesis*,  pharmacology*
Antitubercular Agents / chemical synthesis*,  pharmacology*
Cell Line
HIV Reverse Transcriptase / metabolism
HIV-1 / metabolism
Humans
Isatin / analogs & derivatives*,  chemical synthesis,  pharmacology*
Mannich Bases
Mycobacterium tuberculosis / drug effects,  growth & development
Reverse Transcriptase Inhibitors / pharmacology
Stereoisomerism
Structure-Activity Relationship
Virus Replication / drug effects
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/Antitubercular Agents; 0/Mannich Bases; 0/Reverse Transcriptase Inhibitors; 91-56-5/Isatin; EC 2.7.7.49/HIV Reverse Transcriptase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest f...
Next Document:  Thieno[3,2-c]quinoline-4-yl-amines--synthesis and investigation of activity against malaria